BD will close a facility in Caesarea, Israel, by the middle of the year. BD bought the site along with Caesarea Medical ...

Becton, Dickinson & Co. plans to close its Caesarea Medical Electronics, a producer of infusion pump systems, by June and ...

Levodopa is most commonly administered orally, but this trial tested continuous, 24-hour levodopa delivery through a subcutaneous infusion pump. A total of 381 patients with Parkinson's disease in ...

Developed in 2010, the Regenstrief National Center for Medical Device Informatics (REMEDI) is a flagship software solution that collects infusion pump data from a broad range of manufacturers. REMEDI ...

a New Jersey-based medical device manufacturer known as BD, for repeatedly misleading investors about risks associated with its continued sales of its Alaris infusion pump and for overstating its ...